Literature DB >> 16199893

Cortical-chromaffin cell interactions in the adrenal gland.

Sven Schinner1, Stefan R Bornstein.   

Abstract

Adrenal catecholamines and steroids are important regulators of the stress response, immune function, blood pressure, and energy homeostasis. Historically, the two cell populations within the adrenal gland-the steroid-producing adrenocortical cells and the catecholamine-producing chromaffin cells-have been regarded as two independent endocrine systems. Research on adrenal physiology and pathophysiology has therefore largely focused on the individual understanding of each cell type. However, adrenal cortex and medulla appear to be interwoven and show multiple contact zones without separation by connective tissue or interstitial membranes. In vitro studies, animal models, and the analysis of human adrenal pathophysiology have demonstrated critical importance of cortical-chromaffin crosstalk for adrenal function and disease. Thus, chromaffin cells regulate steroid-hormone release by the adrenal cortex and steroids induce catecholamine production in the medulla. Consequently, disorders of the adrenal cortex have been shown to affect chromaffin cell function and vice versa. Mouse models of adrenal cortical dysfunction, such as the targeted disruption of the 21-hydroxylase- or the CRHR1 genes, show alterations in chromaffin cell function, while disruption of tyrosine hydroxylase, a key enzyme in catecholamine synthesis, impairs adrenal cortical function. Accordingly, patients with congenital adrenal hyperplasia (CAH) and Addison's disease show reduced catecholamine biosynthesis. Immense progress in characterizing the mechanisms of chromaffin-cortical interactions has been achieved in recent years. Here, we summarize the current view on intraadrenal communication with respect to adrenal pathophysiology.

Entities:  

Mesh:

Year:  2005        PMID: 16199893     DOI: 10.1385/ep:16:2:091

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN: 1046-3976            Impact factor:   3.943


  45 in total

1.  Human adrenocortical NCI-H295 cells express VIP receptors. Steroidogenic effect of vasoactive intestinal peptide (VIP).

Authors:  A Haidan; U Hilbers; S R Bornstein; M Ehrhart-Bornstein
Journal:  Peptides       Date:  1998       Impact factor: 3.750

Review 2.  Intraadrenal interactions in the regulation of adrenocortical steroidogenesis.

Authors:  M Ehrhart-Bornstein; J P Hinson; S R Bornstein; W A Scherbaum; G P Vinson
Journal:  Endocr Rev       Date:  1998-04       Impact factor: 19.871

3.  On the presence of chromaffin cells in the adrenal cortex: their possible role in adrenocortical function.

Authors:  N Gallo-Payet; P Pothier; H Isler
Journal:  Biochem Cell Biol       Date:  1987-06       Impact factor: 3.626

4.  Adrenomedullary function is severely impaired in 21-hydroxylase-deficient mice.

Authors:  S R Bornstein; T Tajima; G Eisenhofer; A Haidan; G Aguilera
Journal:  FASEB J       Date:  1999-07       Impact factor: 5.191

5.  Neurotransmitters and neuropeptides in the differential regulation of steroidogenesis in adrenocortical-chromaffin co-cultures.

Authors:  M Ehrhart-Bornstein; A Haidan; S Alesci; S R Bornstein
Journal:  Endocr Res       Date:  2000-11       Impact factor: 1.720

6.  Release of adrenocorticotrophin from the adrenal gland in the conscious calf.

Authors:  C T Jones; A V Edwards
Journal:  J Physiol       Date:  1990-07       Impact factor: 5.182

7.  Plasma catecholamines in patients with Addison's disease.

Authors:  S R Bornstein; M Breidert; M Ehrhart-Bornstein; B Kloos; W A Scherbaum
Journal:  Clin Endocrinol (Oxf)       Date:  1995-02       Impact factor: 3.478

8.  Adrenomedullary function may predict phenotype and genotype in classic 21-hydroxylase deficiency.

Authors:  Evangelia Charmandari; Graeme Eisenhofer; Sarah L Mehlinger; Ann Carlson; Robert Wesley; Margaret F Keil; George P Chrousos; Maria I New; Deborah P Merke
Journal:  J Clin Endocrinol Metab       Date:  2002-07       Impact factor: 5.958

9.  Patients with classic congenital adrenal hyperplasia have decreased epinephrine reserve and defective glucose elevation in response to high-intensity exercise.

Authors:  Martina Weise; Sarah L Mehlinger; Bart Drinkard; Erin Rawson; Evangelia Charmandari; Mayumi Hiroi; Graeme Eisenhofer; Jack A Yanovski; George P Chrousos; Deborah P Merke
Journal:  J Clin Endocrinol Metab       Date:  2004-02       Impact factor: 5.958

10.  Chromaffin cell function and structure is impaired in corticotropin-releasing hormone receptor type 1-null mice.

Authors:  M Yoshida-Hiroi; M J Bradbury; G Eisenhofer; N Hiroi; W W Vale; G E Novotny; H G Hartwig; W A Scherbaum; S R Bornstein
Journal:  Mol Psychiatry       Date:  2002       Impact factor: 15.992

View more
  18 in total

1.  Tyrosine hydroxylase, chromogranin A, and steroidogenic acute regulator as markers for successful separation of human adrenal medulla.

Authors:  Stephanie M J Fliedner; Jan Breza; Richard Kvetnansky; James F Powers; Arthur S Tischler; Robert Wesley; Maria Merino; Hendrik Lehnert; Karel Pacak
Journal:  Cell Tissue Res       Date:  2010-04-30       Impact factor: 5.249

Review 2.  Cytokine interactions with adrenal medullary chromaffin cells.

Authors:  Shirley A Douglas; Dharshini Sreenivasan; Fiona H Carman; Stephen J Bunn
Journal:  Cell Mol Neurobiol       Date:  2010-11-19       Impact factor: 5.046

3.  Pendrin localizes to the adrenal medulla and modulates catecholamine release.

Authors:  Yoskaly Lazo-Fernandez; Greti Aguilera; Truyen D Pham; Annie Y Park; William H Beierwaltes; Roy L Sutliff; Jill W Verlander; Karel Pacak; Adeboye O Osunkoya; Carla L Ellis; Young Hee Kim; Gregory L Shipley; Brandi M Wynne; Robert S Hoover; Shurjo K Sen; Paul M Plotsky; Susan M Wall
Journal:  Am J Physiol Endocrinol Metab       Date:  2015-07-14       Impact factor: 4.310

4.  Interleukin-6-mediated signaling in adrenal medullary chromaffin cells.

Authors:  Danielle E Jenkins; Dharshini Sreenivasan; Fiona Carman; Babru Samal; Lee E Eiden; Stephen J Bunn
Journal:  J Neurochem       Date:  2016-12-05       Impact factor: 5.372

Review 5.  Mixed corticomedullary adrenal carcinoma.

Authors:  Nick Michalopoulos; Kalliopi Pazaitou-Panayiotou; Maria Boudina; Theodossis Papavramidis; Georgia Karayannopoulou; Spiros Papavramidis
Journal:  Surg Today       Date:  2013-02-23       Impact factor: 2.549

6.  Alpha2-adrenoceptor subtypes involved in the regulation of catecholamine release from the adrenal medulla of mice.

Authors:  E Moura; J Afonso; L Hein; M A Vieira-Coelho
Journal:  Br J Pharmacol       Date:  2006-10-30       Impact factor: 8.739

Review 7.  Revisiting the stimulus-secretion coupling in the adrenal medulla: role of gap junction-mediated intercellular communication.

Authors:  Claude Colomer; Michel G Desarménien; Nathalie C Guérineau
Journal:  Mol Neurobiol       Date:  2009-05-16       Impact factor: 5.590

8.  Nongenomic glucocorticoid effects on activity-dependent potentiation of catecholamine release in chromaffin cells.

Authors:  Yong-Soo Park; Yoon Ha Choi; Choon-Ho Park; Kyong-Tai Kim
Journal:  Endocrinology       Date:  2008-06-26       Impact factor: 4.736

9.  Development of the ACTH and corticosterone response to acute hypoxia in the neonatal rat.

Authors:  Eric D Bruder; Jennifer K Taylor; Kimberli J Kamer; Hershel Raff
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-08-13       Impact factor: 3.619

10.  Decreased adrenomedullary function in infants with classical congenital adrenal hyperplasia.

Authors:  Mimi S Kim; Anna Ryabets-Lienhard; Bhavna Bali; Christianne J Lane; Ashley H Park; Sandra Hall; Mitchell E Geffner
Journal:  J Clin Endocrinol Metab       Date:  2014-05-30       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.